Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China
2020-12-01
No Comments
With over 4000 pharmaceutical companies, China is the second-largest pharmaceutical industry globally. A report by Deux Consulting shows that China is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. The October Pharma Sources Insight will provide insights into the Chinese pharmaceutical industry on the following aspects, which offers an industry landscape in China.
滬公網安備31010402000451號